Glenmark Pharmaceuticals Ltd expects to received about 11-12 new U.S. FDA approvals in FY11, its top official said on Friday.
"Typically, we get about 11-12 new approval every year and we anticipate the same number this fiscal," Glenn Saldanha, chief executive and managing director, told a conference call.
Glenmark had received 11 U.S. FDA approvals in FY10 while the number was 10 in FY09, he added.
